In vitro comparison of the photodynamic activity of meso-tetra (m-hydroxyphenyl) chlorin and hematoporphyrin derivative;Comparaison in vitro de l'activite photodynamique de la meso-tetra (m-hydroxyphenyl) chlorine et de l'hematoporphyrine derivee

Bulletin du Cancer

Volumn 83, Issue 10, 1996, Pages 816-822

  Rezzoug, H ^a   Barberi Heyob, M ^a   Merlin, J L ^a   Bolotine, L ^a   Lignon, D ^a   Guillemin, F ^a  

^a CNRS   (France)

Author keywords

cytotoxicity; flow cytometry; hematoporphyrin derivative (HpD); meso tetra (hydroxyphenyl) chlorin (mTHPC); photodynamic therapy

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; TUMOR CELL LINE;

ADENOCARCINOMA; CELL DEATH; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HEMATOPORPHYRIN DERIVATIVE; HUMANS; MESOPORPHYRINS; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0029816841     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Alian W, Andersson-Engels A, Svanberg K, Svanberg S. Laser-induced fluorescence studies of meso-tetra(mhydroxyphenyl) chlorin malignant and normal tissues in rats. Br J Cancer 1994;70:880-5
2. Ash DV, Brown SB. News drugs and future developments in photodynamic therapy. Eur J Cancer 1993;29:1781-3
3. Beems EM, Dubbelman TMAR, Lugtenburg J, Van Best JA, Smeets MEMA, Boegheim JP. Photosensitizing properties of bacteriochlorophyllin a and bacteriochlorin a, two derivatives of bacteriochlorophyll a. Photochem Photobiol 1987;46:639-43
4. Berenbaum MC, Bonnett R, Chevretton EB, Akande-Adebakin SL, Ruston M. Selectivity of meso-tetra(hydroxyphenyl) porphyrins and chlorins and of Photofrin II in causing photodomage in tumour, skin, muscle and bladder, the concept of cost-benefit in analysing the results. Laser Med Sci 1993;8:235-43
5. Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the mesotetra (m-hydroxyphenyl) porphyrin series as tumour photosensitizers. Biochem J 1989;261:277-80
6. Braichotte D, Wagnieres G, Philippoz JM et al. Clinical LIF pharmacokinetic measurements with Photofrin II for optimising the photodetection of early cancer. SPIE 1992;1645: 229-40
7. Clifton Ling C, Chen CH, Fuks Z. An equation for the dose of radiations-induced apoptosis: possible incorporation with the LQ model. Radiother Oncol 1994;33:17-22
8. Chou TC, Talalay C. Quantitative analysis of dose effect relation-ship: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55
9. Cohen S, Margalit R. Binding of porphyrin to human serum albumin. Biochem J 1990;270:325-30
10. Davila J, Harriman A. Photoreactions of macrocyclic dyes bound to Human Serum Albumin. Photochem Photobiol 1990;51:9-19
11. Dougherty TJ. Yearly. Review: Photodynamic Therapy. Photochem Photobiol 1993;58:895-900
12. Dougherty TJ, Grindey OB, Fiel R et al. Photoradiation therapy II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975:115-21
13. Epe B. Genotoxicity of singlet oxygen. Chem Bio Interaction 1991;80:239-60
14. Fenning MC, Brown DQ, Chapman JD. Photodosimetry of interstitial light delivery to solid tumors. Med Phys 1994; 21,7:1149-56
15. Kessel D, Smith KM, Pandey RK, Shiau FY, Henderson B. Photosensitization with bacteriochlorins. Photochem Photobiol 1993;58:200-3
16. Ma L, Moan J, Berg K. Evaluation of new photosensitizer, meso-tetra(hydroxyphenyl) chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer 1994;57:883-8
17. Ma LW, Moan J, Berg K. Comparison of the photobleaching effect of three photosensitizing agents: meso-tetra(m-hydroxyphenyl) chlorin, meso-tetra(m-hydroxyphenyl) porphyrin and photofrin during photodynamic therapy. Laser Med Sci 1994;9:127-32
18. Merlin JL, Azzi S, Lignon D, Ramacci C, Zeghari N, Guillemin F. MTT assays allow quick and reliable measurement of the response of human tumours cells to photodynamic therapy. Eur J Cancer 1992;28:1452-8
19. Meunier- Reynes A, Diebold S, Lignon D, Granjon Y, Guillemin F. Light dosimetry in vivo in interstitial photodynamic therapy of human tumors. SPIE 1991;1525:177-82
20. Michael Titus AT, Whelpton R, Yaqub Z. Binding of temoporphin to the lipoprotein fractions of human serum. Br J Clin Pharmacol 1995;40:594-7
21. Rezzoug H, Meunier-Reynes A, Merlin JL et al. Évaluation de la profondeur de pénétration de la lumière utilisée en thérapie photodynamique in vivo dans des xénogreffes tumorales. Bull Cancer 1994:553
22. Ris HB, Altermati HJ, Nachbur B et al. Photodynamic therapy with metatetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index. Int J Cancer 1993;55:245-9
23. Ris HB, Altermati HJ, Nachbur B et al. Effect of drug-light interval on photodynamic therapy with m-Tetrahydroxy-phenylchlorin in malignant mesothelioma. Int J Cancer 1993;53:141-6
24. Rotenberg M, Cohen S, Margali R. Thermodynamic of porphyrins binding to serum albumin: effects of temperature, of pophyrin species and of albumin- carried fatty acids. Photochem Photobiol 1987;46:689-93
25. Shuitmaker JJ, Vrensen GFJM, Van Delft JL, Wolff Rouendaal D, Dubbelman TMAR, Wolf A. Morphologic effects of bacteriochlorin a and light in vivo on intraocular melanoma. Ophtal Visual Sci 1991;32:2683-8
26. Schuitmaker JJ, Van Leengoed HLLM, Van Der Veen N, Dubbelman TMAR. Laser-induced in vivo fluorescence of Bacteriochlorine a: Preliminary results. Laser Med Sci 1993; 8:39-42